Holzer, M.; Schade, N.; Opitz, A.; Hilbrich, I.; Stieler, J.; Vogel, T.; Neukel, V.; Oberstadt, M.; Totzke, F.; Schächtele, C.;
et al. Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay. Molecules 2018, 23, 2335.
https://doi.org/10.3390/molecules23092335
AMA Style
Holzer M, Schade N, Opitz A, Hilbrich I, Stieler J, Vogel T, Neukel V, Oberstadt M, Totzke F, Schächtele C,
et al. Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay. Molecules. 2018; 23(9):2335.
https://doi.org/10.3390/molecules23092335
Chicago/Turabian Style
Holzer, Max, Nico Schade, Ansgar Opitz, Isabel Hilbrich, Jens Stieler, Tim Vogel, Valentina Neukel, Moritz Oberstadt, Frank Totzke, Christoph Schächtele,
and et al. 2018. "Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay" Molecules 23, no. 9: 2335.
https://doi.org/10.3390/molecules23092335
APA Style
Holzer, M., Schade, N., Opitz, A., Hilbrich, I., Stieler, J., Vogel, T., Neukel, V., Oberstadt, M., Totzke, F., Schächtele, C., Sippl, W., & Hilgeroth, A.
(2018). Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay. Molecules, 23(9), 2335.
https://doi.org/10.3390/molecules23092335